Pharma compliance operations and global rules

Open Payments vs. Aggregate Spend Reporting: What Differs

How Open Payments differs from aggregate spend reporting: what each covers, who reports, state laws, and what marketing and media teams need to track.

Christian Guerrero Published 3 min read Part 2 of 10

The short answer

Open Payments is the federal transparency program, run by CMS under the Sunshine Act, in which manufacturers report payments and transfers of value to covered recipients such as physicians, certain other clinicians, and teaching hospitals. Aggregate spend is a company's internal process of capturing and totaling all spend on HCPs and organizations, which feeds Open Payments, state reports, and company caps. Marketing teams create many reportable events, so they need to capture details accurately.

"Open Payments" and "aggregate spend" are often used interchangeably. They are related but not the same, and the difference matters for anyone running events, sponsorships, or HCP programs.

Definitions

Open Payments Aggregate spend
What it is Federal reporting program run by CMS Company process for tracking all HCP and HCO spend
Legal basis Sunshine Act provisions, 42 CFR Part 403 Internal policy, supporting federal, state, and international reporting
Scope Covered recipients defined by CMS Usually broader: all HCPs, HCOs, sometimes international
Output Annual federal report, public database Internal records feeding many reports and spending caps

Who is covered in Open Payments

CMS defines covered recipients. They include physicians and teaching hospitals, and the program was expanded to include physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives. Check CMS for current definitions and thresholds.

State laws

Several states have their own reporting requirements, gift bans, or spending limits, and some cover groups not in Open Payments. Aggregate spend systems exist largely to handle this patchwork.

Where marketing creates reportable events

Activity Possible reporting
Speaker programs Honoraria, travel, meals
Advisory boards Fees, travel
Meals with HCPs Food and beverage
Educational items Value of items, where allowed
Market research Depends on structure and whether the sponsor is known
Sponsorships involving HCPs Depends on structure
Ordinary ad placements Generally not, as payments go to publishers

Media teams rarely make payments to HCPs directly. Event, research, and partnership work can, so involve compliance early.

What teams must capture

  • HCP identity, including NPI.
  • Date, nature, and value of the transfer.
  • Related product.
  • Purpose and context.
  • Vendor or agency that made the payment on the company's behalf.

Agencies and vendors often pay HCPs on behalf of the company. Contracts should require them to report details back.

Common mistakes

  • Assuming agencies handle reporting without contract terms.
  • Missing NPs and PAs, now covered recipients.
  • Inconsistent HCP identities across vendors.
  • Late capture leading to reporting errors.

Practical takeaway

For any program involving HCPs, add a line to the brief: "transfers of value expected? who captures them?" Answering it at the start prevents most aggregate spend problems.

Frequently asked questions

Who must report to Open Payments?

Applicable manufacturers and group purchasing organizations, as defined by CMS, report payments and transfers of value to covered recipients.

Who are covered recipients?

Physicians, teaching hospitals, and, since program expansion, physician assistants, nurse practitioners, clinical nurse specialists, certified registered nurse anesthetists, and certified nurse midwives, as defined by CMS.

Do media buys count as payments to HCPs?

Ordinary advertising placements bought from publishers generally do not. Payments or items of value to HCPs, such as honoraria, meals, or sponsorships involving HCPs, may.

Sources

External guidance and platform documentation change. Links were current at publication; check them again before relying on them for a decision.

Editorial note. Analysis and frameworks are the author's own and do not represent Acxiom or any current or former employer, client, or named platform. Examples labeled hypothetical or illustrative are not results from real campaigns. Nothing here is legal, regulatory, or medical advice.

Working through this decision on a real plan?

I work on health and pharma data, identity, and activation, after five years running HCP and DTC programmatic agency-side. Happy to talk through how this applies to your situation.